Public-domain · open source
OpenJurist
← 217 FSUPP2D 80 - Neil Laboratories, Inc. v. Ashcroft

Neil Laboratories, Inc. v. Ashcroft’s Empirical Analysis

2002

Citation profile

3
cited by 3 later decisions
March 2012
most recently cited

3 district ·

Relationships

Applies 21 U.S.C. § 801 (§ 101 of the Controlled Substances Act) · 21 U.S.C. § 802 (§ 102 of the Controlled Substances Act) · 21 U.S.C. § 824 (§ 304 of the Controlled Substances Act) · 21 U.S.C. § 872 (§ 502 of the Controlled Substances Act) · 5 U.S.C. § 701 · 5 U.S.C. § 702 · 5 U.S.C. § 704 · 5 U.S.C. § 706

Relies on Anderson v. Liberty Lobby, Inc. · Celotex Corporation v. Catrett H · Citizens to Preserve Overton Park, Inc. v. Volpe · Motor Vehicle Manufacturers Association of United States Inc v. State Farm Mutual Automobile Insurance Company Consumer Alert · Califano v. Sanders

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 3 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “The scope of review under the “arbitrary and capricious” standard is narrow and a court is not to substitute its judgment for that of the agency. Nevertheless, the agency must examine the relevant data and articulate a satisfactory explanation for its action[,] including a rational connection between the facts found and the choice made. In reviewing that explanation, we must consider whether the decision was based on a consideration of the relevant factors and whether there has been a clear error of judgment. Normally, an agency [action] would be arbitrary and capricious if the agency has relied on factors which Congress has not intended it to consider, entirely failed to consider an important aspect of the problem, offered an explanation for its decision that runs counter to the evidence before the agency, or is so implausible that it could not be ascribed to a difference in view or the product of agency expertise.”
    2 later decisions quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.